Heterologous immunity triggered by a single, latent virus in Mus musculus: combined costimulation- and adhesion- blockade decrease rejection.
Heterologous immunity triggered by a single, latent virus in Mus musculus: combined costimulation- and adhesion- blockade decrease rejection.
复制标题
DOI:
10.1371/journal.pone.0071221
复制
发表时间:
2013
期刊:
影响因子:
3.7
通讯作者:
Kean LS
中科院分区:
文献类型:
--
作者:
Beus JM;Hashmi SS;Selvaraj SA;Duan D;Stempora LL;Monday SA;Cheeseman JA;Hamby KM;Speck SH;Larsen CP;Kirk AD;Kean LS
The mechanisms underlying latent-virus-mediated heterologous immunity, and subsequent transplant rejection, especially in the setting of T cell costimulation blockade, remain undetermined. To address this, we have utilized MHV68 to develop a rodent model of latent virus-induced heterologous alloimmunity. MHV68 infection was correlated with multimodal immune deviation, which included increased secretion of CXCL9 and CXCL10, and with the expansion of a CD8dim T cell population. CD8dim T cells exhibited decreased expression of multiple costimulation molecules and increased expression of two adhesion molecules, LFA-1 and VLA-4. In the setting of MHV68 latency, recipients demonstrated accelerated costimulation blockade-resistant rejection of skin allografts compared to non-infected animals (MST 13.5 d in infected animals vs 22 d in non-infected animals, p<.0001). In contrast, the duration of graft acceptance was equivalent between non-infected and infected animals when treated with combined anti-LFA-1/anti-VLA-4 adhesion blockade (MST 24 d for non-infected and 27 d for infected, p = n.s.). The combination of CTLA-4-Ig/anti-CD154-based costimulation blockade+anti-LFA-1/anti-VLA-4-based adhesion blockade led to prolonged graft acceptance in both non-infected and infected cohorts (MST>100 d for both, p<.0001 versus costimulation blockade for either). While in the non-infected cohort, either CTLA-4-Ig or anti-CD154 alone could effectively pair with adhesion blockade to prolong allograft acceptance, in infected animals, the prolonged acceptance of skin grafts could only be recapitulated when anti-LFA-1 and anti-VLA-4 antibodies were combined with anti-CD154 (without CTLA-4-Ig, MST>100 d). Graft acceptance was significantly impaired when CTLA-4-Ig alone (no anti-CD154) was combined with adhesion blockade (MST 41 d). These results suggest that in the setting of MHV68 infection, synergy occurs predominantly between adhesion pathways and CD154-based costimulation, and that combined targeting of both pathways may be required to overcome the increased risk of rejection that occurs in the setting of latent-virus-mediated immune deviation.
登录
查看更多内容
影响因子:
2.3
作者:
Lima, M;Teixeira, MD;Justiça, B
通讯作者:
Justiça, B
影响因子:
30.5
作者:
Kaech, SM;Tan, JT;Ahmed, R
通讯作者:
Ahmed, R
影响因子:
4.8
作者:
Ko, J;Jang, SW;Na, DS
通讯作者:
Na, DS
影响因子:
5.4
作者:
Lee, BJ;Giannoni, F;Sarawar, SR
通讯作者:
Sarawar, SR
DOI:
10.1111/j.1600-6143.2011.03762.x
发表时间:
2012-01
期刊:
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
影响因子:
--
作者:
Kitchens WH;Haridas D;Wagener ME;Song M;Kirk AD;Larsen CP;Ford ML
通讯作者:
Ford ML